Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114.6 EUR | +0.09% | +1.87% | +6.21% |
May. 02 | Ipsen Announces Executive Changes | CI |
May. 02 | Ipsen: new President for North America | CF |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.21% | 10.19B | B+ | ||
+31.52% | 662B | C+ | ||
+21.96% | 546B | B | ||
-5.21% | 359B | C+ | ||
+17.02% | 323B | B- | ||
+5.01% | 289B | C+ | ||
+13.68% | 234B | B+ | ||
+3.81% | 198B | B- | ||
-10.63% | 194B | A+ | ||
+3.98% | 167B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- IPN Stock
- Ratings Ipsen